CN103637836A - Intrauterine adhesion prevention and treatment device - Google Patents
Intrauterine adhesion prevention and treatment device Download PDFInfo
- Publication number
- CN103637836A CN103637836A CN201310675562.1A CN201310675562A CN103637836A CN 103637836 A CN103637836 A CN 103637836A CN 201310675562 A CN201310675562 A CN 201310675562A CN 103637836 A CN103637836 A CN 103637836A
- Authority
- CN
- China
- Prior art keywords
- sacculus
- summit
- balloon
- support
- intrauterine adhesion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/007—Injectors for solid bodies, e.g. suppositories
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
- A61F6/16—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
- A61F6/18—Inserters or removers ; Apparatus for loading an intra-uterine device into an insertion tube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B2017/4216—Operations on uterus, e.g. endometrium
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides an intrauterine adhesion prevention and treatment device. The intrauterine adhesion prevention and treatment device comprises a triangular balloon, a balloon catheter, a catheter base, a balloon support and medicine sustained-release capsules, wherein the balloon catheter is connected with the first vertex of the balloon and communicated with the interior of the balloon, the catheter base is connected with the end, away from the balloon, of the balloon catheter, the medicine sustained-release capsules are used for storing medicine and releasing the medicine gradually in the vivo environment, the two ends of the balloon support are connected with the second vertex and the third vertex of the balloon respectively, a position point of the balloon support is located at the first vertex of the balloon, and the medicine sustained-release capsules are arranged at the two ends of the balloon support. By means of the intrauterine adhesion prevention and treatment device, intrauterine adhesion can be effectively prevented in a short term or a long term, a second operation for replacing an intrauterine device is not needed any more, and the problem that restoration of the endometrium of a patient in whom estrogenic hormones and progestational hormones are contraindicated is slow because the patient can not take the hormones orally is also solved.
Description
Technical field
The invention belongs to medical instruments field, relate in particular to a kind of intrauterine adhesion control device.
Background technology
At present, still do not have clinically a kind of special apparatus or instrument to prevent intrauterine adhesion, conventional method is that postoperative placement sacculus uterus support is to reduce metrorrhagia, and take the treatment that estrogen and progestogen carries out artificial cycle, to promote endometrial reparation and regeneration, and behind about 3 months of placement sacculus uterus support, sacculus uterus support is taken out, then placement of intrauterine devices prevents intrauterine adhesion at a specified future date.And the deficiency that above-mentioned these methods exist is:
1, troublesome poeration, it is larger that patient need carry out three operation (once place uterus support, once take out uterus support, once place birth control apparatus) wounds, and simultaneously surgery cost is higher.
2, because later stage intrauterine device surface area used is too small, be difficult to prevent intrauterine adhesion at a specified future date, especially cervical adhesion.
3, there is estrogen and progestogen to take taboo person and cannot carry out the treatment of artificial cycle, thereby cause endometrium reparation to delay, hemorrhage many, leave sequela.Common medicine contraindication disease has: acute and chronic hepatorenal disease, serious cardiovascular disease, hematopathy or thrombotic disease, genitals's tumor, malignant tumor, precancerous lesion, endocrinopathy and mentally disturbed etc.
4, the patient that great majority need carry out endometrium operation exists inner membrance pathological changes, and the postoperative estrogen and progestogen of taking can cause endometrium canceration.
Summary of the invention
The object of the present invention is to provide a kind of intrauterine adhesion control device, the method complex operation, the damage that are intended to solve existing prevention intrauterine adhesion are large, expense is high, and the problem such as weak effect.
The present invention realizes like this, a kind of intrauterine adhesion control device, comprise the leg-of-mutton sacculus being linked to be by the first summit, the second summit and the 3rd summit, be connected with the first summit of described sacculus and with the foley's tube of the inner conducting of sacculus, the catheter block being connected away from sacculus direction one end with described foley's tube, sacculus support, and for storage of pharmaceutical and progressively discharge the medicament slow release capsule of medicine at human body environment; Wherein,
Described sacculus support two ends are connected with the 3rd summit with sacculus the second summit respectively, and on described sacculus support, have a location point to be positioned at sacculus the first place, summit;
Described medicament slow release capsule is located on sacculus or sacculus support.
Preferably, described medicament slow release capsule is located on second summit and/or the 3rd summit of sacculus.
Preferably, described medicament slow release capsule is located on capsule support and is positioned at described the first place, summit.
Preferably, the stored medicine of described medicament slow release capsule is estrogen and progestogen slow releasing agent
The present invention overcomes the deficiencies in the prior art, a kind of intrauterine adhesion control device is provided, comprise leg-of-mutton sacculus, be connected with the first summit of sacculus and with the foley's tube of the inner conducting of sacculus, the catheter block being connected away from sacculus direction one end with foley's tube, sacculus support, and for storage of pharmaceutical and progressively discharge the medicament slow release capsule of medicine at human body environment; Wherein, sacculus support two ends are connected with the 3rd summit with sacculus the second summit respectively, and on sacculus support, have a location point to be positioned at sacculus the first place, summit; Described medicament slow release capsule is located on sacculus or sacculus support.Sacculus of the present invention has effectively prevented intrauterine adhesion afterwards in inflation, although and no longer full after silicon balloon membrane venting, still can play the effect of isolation uterine cavity front and rear wall, reduced intrauterine adhesion at a specified future date, in this simultaneously, sacculus support has just played the effect of intrauterine device, only sacculus need be exitted, secondary and even three the hands arts that needn't need carry out because sacculus being inserted again to intrauterine device, finally, the introducing of estrogen and progestogen slow releasing capsule of the present invention, can effectively promote endometrium regeneration, reduce metrorrhagia, make the patient of medicine contraindication also can repair smoothly rapidly endometrium, and a series of bad complication of having avoided oral drugs to bring.
Accompanying drawing explanation
Fig. 1 is the structural representation of intrauterine adhesion control device of the present invention one embodiment.
The specific embodiment
In order to make object of the present invention, technical scheme and advantage clearer, below in conjunction with drawings and Examples, the present invention is further elaborated.Should be appreciated that specific embodiment described herein, only in order to explain the present invention, is not intended to limit the present invention.
As shown in Figure 1, wherein, Fig. 1 is the structural representation of intrauterine adhesion control device of the present invention one embodiment.
A kind of intrauterine adhesion control device, comprise leg-of-mutton sacculus 3, be connected with described sacculus 3 first summits and with the foley's tube 4 of sacculus 3 inner conductings, the catheter block 5 being connected away from sacculus 3 direction one end with described foley's tube 4, sacculus support 2, and for storage of pharmaceutical and progressively discharge the medicament slow release capsule 1 of medicine at human body environment; Wherein, described sacculus support 2 two ends are connected with the 3rd summit with sacculus 3 second summits respectively, and on described sacculus support 3, have a location point to be positioned at sacculus 3 first places, summit; Described medicament slow release capsule 1 is located on sacculus 3 or sacculus support 2.
More specifically, in embodiments of the present invention, described medicament slow release capsule 1 is located on second summit and/or the 3rd summit of sacculus 3, and the stored medicine of medicament slow release capsule 1 is estrogen and progestogen slow releasing agent; Sacculus props up 2, and for V font, the two ends that upwarp of V shaped ball rami capsulares frame 2 are connected with the 3rd summit with second of sacculus 3 respectively, and bottom is positioned at the first place, summit of sacculus 3.
In the present invention, sacculus 3, foley's tube 4, catheter block 5 all have silastic material preparation, and sacculus support 2 is made by plastic material.
In actual application of the present invention, the present invention is placed in after women's intrauterine, by catheter block 5, be connected with syringe, by syringe injection air and via foley's tube 4 Filled Balloons 3, because sacculus 3 is del, meet women uterus normal physiological form, after sacculus 3 inflations, can maintain uterine cavity edge separation, prevent that intrauterine adhesion from occurring.In addition, foley's tube 4 enters vagina via uterine cavity pipe, also can effectively play the effect of the generation that prevents intrauterine adhesion.
After endometrium is repaired a period of time (approximately 1～3 month, the concrete condition that the concrete time repairs depending on endometrium), under uterine cavity collar extension, 1cm after cutting off at place foley's tube 4 exits sacculus 3, although no longer full after sacculus 3 venting, but be still positioned at uterine cavity, still can play the effect of isolation uterine cavity front and rear wall, reduced intrauterine adhesion at a specified future date, in addition, foley's tube also can play the effect that prevents cervical adhesion.
In addition, in the embodiment of the present invention, medicament slow release capsule 1 is positioned at palace, the both sides Jiao Chu of uterine cavity, silica gel, consists of, can regularly in uterine cavity, discharge estrogen and progestogen, thereby promote reparation and the regeneration of inner membrance, no longer need the oral estrogen and progestogen class of patient medicine, so, can make the patient's of medicine contraindication disease endometrium can be able to quick reparation on the one hand, on the other hand, because the local orientation of medicine discharges, and then greatly reduced the side effect that brings because of oral estrogen and progestogen class medicine.
Meanwhile, in the embodiment of the present invention, sacculus support 2 forms conform to the form of uterine cavity " inverted triangle ", good with uterus stickiness, not only can well play the effect of intrauterine device, and can prevent intrauterine adhesion at a specified future date.Complete when endometrium reparation, only sacculus gas need be emitted, the present invention can stay in uterine cavity and continue to use, and has reduced or remitted the operation technique of secondary placement birth control apparatus.
Compare the shortcoming and defect with prior art, the present invention has following beneficial effect:
1, the sacculus after the present invention's inflation has effectively prevented intrauterine adhesion, meanwhile, although no longer full after balloon membrane venting, still can play the effect of isolation uterine cavity front and rear wall, reduced intrauterine adhesion at a specified future date, in addition, foley's tube also can play the effect that prevents cervical adhesion.
2, the present invention can guarantee that postoperative endometrium repairs, and only sacculus need be exitted, and needn't take out, and the sacculus support in this invention has just played the effect of intrauterine device, without secondary and even three operations.
3, the introducing of estrogen and progestogen slow releasing capsule of the present invention, can effectively reduce metrorrhagia, makes the patient of medicine contraindication also can repair smoothly rapidly endometrium, and a series of bad complication of having avoided oral drugs to bring.
The foregoing is only preferred embodiment of the present invention, not in order to limit the present invention, all any modifications of doing within the spirit and principles in the present invention, be equal to and replace and improvement etc., within all should being included in protection scope of the present invention.
Claims (4)
1. an intrauterine adhesion is prevented and treated device, it is characterized in that, comprise the leg-of-mutton sacculus being linked to be by the first summit, the second summit and the 3rd summit, be connected with the first summit of described sacculus and with the foley's tube of the inner conducting of sacculus, the catheter block being connected away from sacculus direction one end with described foley's tube, sacculus support, and for storage of pharmaceutical and progressively discharge the medicament slow release capsule of medicine at human body environment; Wherein,
Described sacculus support two ends are connected with the 3rd summit with sacculus the second summit respectively, and on described sacculus support, have a location point to be positioned at sacculus the first place, summit;
Described medicament slow release capsule is located on sacculus or sacculus support.
2. intrauterine adhesion control device as claimed in claim 1, is characterized in that, described medicament slow release capsule is located on second summit and/or the 3rd summit of sacculus.
3. intrauterine adhesion control device as claimed in claim 1, is characterized in that, described medicament slow release capsule is located on capsule support and is positioned at described the first place, summit.
4. the control of the intrauterine adhesion as described in claims 1 to 3 any one device, is characterized in that, the stored medicine of described medicament slow release capsule is estrogen and progestogen slow releasing agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310675562.1A CN103637836A (en) | 2013-12-13 | 2013-12-13 | Intrauterine adhesion prevention and treatment device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310675562.1A CN103637836A (en) | 2013-12-13 | 2013-12-13 | Intrauterine adhesion prevention and treatment device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103637836A true CN103637836A (en) | 2014-03-19 |
Family
ID=50243228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310675562.1A Pending CN103637836A (en) | 2013-12-13 | 2013-12-13 | Intrauterine adhesion prevention and treatment device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103637836A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105268090A (en) * | 2015-09-01 | 2016-01-27 | 北京中科盛康科技有限公司 | Medicine application device for controlling intrauterine adhesion |
| WO2016061692A1 (en) * | 2014-10-22 | 2016-04-28 | Jmd Innovation | Anti-adhesion intrauterine balloon |
| CN106344230A (en) * | 2016-08-18 | 2017-01-25 | 马安军 | Anti-intrauterine adhesion device |
| WO2017184669A1 (en) * | 2016-04-20 | 2017-10-26 | Duke University | Intrauterine adhesion barrier device and method of use |
| CN107736910A (en) * | 2017-11-15 | 2018-02-27 | 蔡华蕾 | A kind of easily multi-functional uterine cavity resilient bladder support of putting type |
| CN110917478A (en) * | 2019-12-10 | 2020-03-27 | 河南省肿瘤医院 | Drug slow-release device for cervical HPV infection |
| CN112386376A (en) * | 2019-08-12 | 2021-02-23 | 石海波 | Uterus anti-adhesion support for preventing and treating uterus intrauterine adhesion and use method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102657546A (en) * | 2012-05-16 | 2012-09-12 | 段华 | Carrier barrier system applied to prevention and treatment of metrosynizesis |
| CN202637025U (en) * | 2012-07-10 | 2013-01-02 | 武汉半边天医疗技术发展有限公司 | Sacculus uterine support |
| CN103301558A (en) * | 2013-06-25 | 2013-09-18 | 杭州安体科技有限公司 | Inductive uterine slow release system |
-
2013
- 2013-12-13 CN CN201310675562.1A patent/CN103637836A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102657546A (en) * | 2012-05-16 | 2012-09-12 | 段华 | Carrier barrier system applied to prevention and treatment of metrosynizesis |
| CN202637025U (en) * | 2012-07-10 | 2013-01-02 | 武汉半边天医疗技术发展有限公司 | Sacculus uterine support |
| CN103301558A (en) * | 2013-06-25 | 2013-09-18 | 杭州安体科技有限公司 | Inductive uterine slow release system |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016061692A1 (en) * | 2014-10-22 | 2016-04-28 | Jmd Innovation | Anti-adhesion intrauterine balloon |
| CN107106823A (en) * | 2014-10-22 | 2017-08-29 | Jmd创新公司 | Resist blocking and that uterine cavity sacculus |
| CN105268090A (en) * | 2015-09-01 | 2016-01-27 | 北京中科盛康科技有限公司 | Medicine application device for controlling intrauterine adhesion |
| WO2017184669A1 (en) * | 2016-04-20 | 2017-10-26 | Duke University | Intrauterine adhesion barrier device and method of use |
| CN106344230A (en) * | 2016-08-18 | 2017-01-25 | 马安军 | Anti-intrauterine adhesion device |
| CN107736910A (en) * | 2017-11-15 | 2018-02-27 | 蔡华蕾 | A kind of easily multi-functional uterine cavity resilient bladder support of putting type |
| CN112386376A (en) * | 2019-08-12 | 2021-02-23 | 石海波 | Uterus anti-adhesion support for preventing and treating uterus intrauterine adhesion and use method thereof |
| CN110917478A (en) * | 2019-12-10 | 2020-03-27 | 河南省肿瘤医院 | Drug slow-release device for cervical HPV infection |
| CN110917478B (en) * | 2019-12-10 | 2020-11-24 | 河南省肿瘤医院 | Drug slow-release device for cervical HPV infection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103637836A (en) | Intrauterine adhesion prevention and treatment device | |
| CN103784244B (en) | A kind of intrauterine implant | |
| ES2930330T3 (en) | Elastic membrane having a function of reactivation of the endometrial basal layer in a uterine cavity and preparation method of the elastic membrane | |
| CN103417272B (en) | A kind of medicine distribution type uterus support | |
| Fouda et al. | Optimal timing of misoprostol administration in nulliparous women undergoing office hysteroscopy: a randomized double-blind placebo-controlled study | |
| CN105078642A (en) | Implant for uteruses | |
| CN203074828U (en) | Anti-adhesion membrane for uterine cavity | |
| CN103301558B (en) | Inductive uterine slow release system | |
| CN110559061B (en) | Anti-adhesion Zhang Ligong-cavity-free adaptive barrier and application method thereof | |
| CN201404586Y (en) | Implanted device of non-sticking sticking membrane of uterine cavity | |
| CN210472770U (en) | Oviduct radiography and liquid-flowing catheter | |
| CN204932561U (en) | Cervical dilator | |
| CN207970119U (en) | Liver and gall surgical department's ball-bag dilation tube | |
| CN201131825Y (en) | Vagina shaping dilator | |
| CN203842165U (en) | Three-balloon cervical dilation balloon catheter | |
| CN205251653U (en) | Curette is revolved in induced abortion | |
| CN203329172U (en) | Device for preventing and treating intrauterine adhesion and cervical adhesion | |
| CN205041959U (en) | Prevent integral type lumen sacculus of cervical adhesion | |
| Huertas-Velasco et al. | Endoscopic removal of intrauterine device penetrated through the rectal wall | |
| CN204293125U (en) | Visual uterine dilator | |
| CN203341802U (en) | Induction-type uterine cavity delay release system | |
| CN203539420U (en) | Medicine-distribution type uterus stent | |
| CN205072988U (en) | Antiseized even apparatus in palace chamber | |
| Yen et al. | Interstitial pregnancy | |
| CN208002943U (en) | The guiding tube that a kind of auxiliary sacculus uterus holder is placed |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140319 |
|
| RJ01 | Rejection of invention patent application after publication |